TNFα signals through specialized factories where responsive coding and miRNA genes are transcribed

Argyris Papantonis, Takahide Kohro, Sabyasachi Baboo, +15

The EMBO Journal

The proteomes of transcription factories containing RNA polymerases I, II or III

Svitlana Melnik, Binwei Deng, Argyris Papantonis, +3

Nature Methods

Transcriptional RegulationRna PolymerasesMedicineTranscription FactoriesNatural Sciences +9

Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors

Jordan R. Willis, Zachary T. Berndsen, Mark Krystal, +26

Immunity

mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies

Zhenfei Xie, Ying‐Cing Lin, Jon M. Steichen, +30

Science

Identification of new transmembrane proteins concentrated at the nuclear envelope using organellar proteomics of mesenchymal cells

Li-Chun Cheng, Sabyasachi Baboo, Cory Lindsay, +6

Nucleus

Molecular BiologyCellular PhysiologyProteomic TechnologyNew Transmembrane ProteinsNuclear Envelope +18

Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates

Jon M. Steichen, Ivy Phung, Eugenia Salcedo, +38

Science

VaccinationVaccine PrimingVaccine DevelopmentVaccine ResearchHiv Envelope Trimer +13

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

Torben Schiffner, Ivy Phung, Rashmi Ray, +72

Nature Immunology

Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice

Christopher A. Cottrell, Xiaozhen Hu, Jeong Hyun Lee, +34

Science Translational Medicine

Most Human Proteins Made in Both Nucleus and Cytoplasm Turn Over within Minutes

Sabyasachi Baboo, Bhaskar Bhushan, Haibo Jiang, +4

PLoS ONE

Intercepting IRE1 kinase‐FMRP signaling prevents atherosclerosis progression

Sabyasachi Baboo, Syed Muhammad Hamid, Asli Ekin Dogan, +14

EMBO Molecular Medicine

InflammationVascular DiseaseSignal TransductionAtherosclerosisIre1 Kinase‐fmrp +5